Study reveals hidden risks for CMV infection in kidney transplant patients
NCT ID NCT07621835
First seen Jun 06, 2026 · Last updated Jun 14, 2026 · Updated 1 time
Summary
This study looked at 236 kidney transplant patients to find out why some fail to develop a strong immune response against the common CMV virus in the first 45 days after surgery. Researchers reviewed medical records and blood test results to identify risk factors. The goal is to help doctors predict and manage CMV reactivation more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HOSPITAL Universitario REINA SOFIA
Córdoba, 14004, Spain
Conditions
Explore the condition pages connected to this study.